Find clinical trials for Multiple Sclerosis (MS) in San Diego, CA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Multiple Sclerosis (MS) trials near San Diego, CA, USA:
The goal of this clinical trial is to treat male and female participants with two types of Multiple Sclerosis (MS) called ...
Phase 1, Phase 2
La Jolla, California, United States and 7 other locations
The main objective of the study is to determine the recommended phase 2 dose (RP2D) of Azercabtagene zapreleucel (azer-cel).
Phase 1
La Jolla, California, United States and 7 other locations
due to cancer or other illnesses such as Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), Parkinson'...
Phase 2
San Diego, California, United States and 31 other locations
SC reference formulation in participants with either relapsing multiple sclerosis (RMS) or primary progressive multiple sc...
Phase 2
Carlsbad, California, United States and 49 other locations
ocrelizumab subcutaneous (SC) test formulation in participants with multiple sclerosis (MS). The study consists of two tre...
Phase 1
Carlsbad, California, United States and 11 other locations
This study will evaluate the safety, tolerability, and descriptive efficacy of BIIB017 in pediatric participants with relapsing-remitting multiple...
Phase 3
La Jolla, California, United States and 65 other locations
This double-blind, double-dummy study will evaluate the safety and efficacy of ocrelizumab compared with fingolimod in children and adolescents with...
Phase 3
La Jolla, California, United States and 71 other locations
antigen receptor T-cell therapy, in participants with progressive multiple sclerosis refractory to standard-of-care therapy. The st ...
Phase 1, Phase 2
La Jolla, California, United States and 1 other location
To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...
Phase 3
Chula Vista, California, United States and 201 other locations
A Phase I Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for Pediatric Multiple Sclerosis to demonstrate safety \& eff...
Phase 1
San Diego, California, United States
Clinical trials
Research sites
Resources
Legal